SEC Filings

8-K
PERNIX THERAPEUTICS HOLDINGS, INC. filed this Form 8-K on 02/27/2019
Entire Document
 

Schedule P-1

 

Permitted Investments

 

Pernix Therapeutics Holdings, Inc. – 10% interest in Nalpropion Pharmaceuticals, Inc.

 

Schedule P-1